Key facts
- It has raised $100K; the latest was Accelerator/Incubator in Sep 2025.
- Notable investors include Tech Incubator Program for Startup, Korea Development Bank, Enlight Ventures, Posco Investment, Lotte Ventures — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for ANPOLY
- ·The full record, as it builds
Funding rounds
No funding rounds for ANPOLY are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ANPOLY
Developer of a non-toxic, biodegradable, and biocompatible biopolymer designed to be used extensively in biomedical applications. The company offers nano-chitin by extracting cellulose from rice husks, which are applied in tissue scaffolds, drug delivery, and wound dressings, enabling companies to replace various synthetic polymers, including plastics.
- Sector
- Materials and Resources
- HQ
- Pohang, South Korea
- Founded
- 2017
- Employees
- 28
- Website
- anpolyinc.com/
- Ownership
- Privately Held (backing)
ANPOLY doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ANPOLY shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ANPOLY in its N-PORT filings yet. We sweep new filings monthly.